Moderna (NASDAQ:MRNA) announced on Monday a new collaboration with an international health organization aimed at accelerating ...

Moderna secures up to $50 million to develop an Ebola vaccine.

Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support ...

Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports ...

AFP / Moderna shares are surging after a report the drugmaker confirmed it's working on a potential hantavirus vaccine. Several people have tested positive for the rare hantavirus on the cruise ship ...

The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes strain's high mortality rate underscores the urgency for effective solutions.

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

The vaccine was pioneered by S. Korea, while collaboration between Korea University & Moderna since 2023 has only been ...